Pediatrix Medical Group I... (MD)

MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects.

The mean of analysts' price targets for Pediatrix Medical Group (MD) points to a 26.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement ...

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks presents investors with the ...

Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several ...

MD anticipates adjusted EBITDA to be between $220 million and $240 million in 2025.

Pediatrix Medical Group, Inc. (NYSE:MD ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Mark Ordan - Chief Executive Officer Kasandra Rossi - Chief Financial Officer Conf...

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.20 per share a year ago.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.

Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks offers value investors a better ba...

MD's first-quarter results are likely to reflect declining hospital contract administrative fees.